Orchard Therapeutics Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Jul '25 Jul 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Market Capitalization	29	23	-	-
Enterprise Value	24	21	-	-
Last Close Price	0.39	0.30	-	-
PS Ratio	2.48	2.26	-	-
PB Ratio	2.31	1.95	-	-
P/TBV Ratio	5.01	4.55	-	-
P/OCF Ratio	98.64	143.56	-	-
EV/Sales Ratio	2.06	2.07	-	-
EV/EBITDA Ratio	23.74	42.28	-	-
EV/EBIT Ratio	25.85	42.30	-	-
Debt / Equity Ratio	0.01	0.01	-	0.13
Debt / EBITDA Ratio	0.10	0.26	-	-
Asset Turnover	1.01	1.24	2.95	-
Quick Ratio	6.79	3.67	6.27	6.07
Current Ratio	6.82	3.84	6.27	6.07
Return on Equity (ROE)	4.09%	-3.64%	9.20%	-
Return on Assets (ROA)	5.04%	3.79%	5.95%	-
Return on Capital (ROIC)	5.88%	4.26%	6.61%	-
Return on Capital Employed (ROCE)	7.40%	4.20%	10.00%	8.30%
Earnings Yield	1.37%	-1.14%	-	-
Buyback Yield / Dilution	-38.38%	-9.71%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.